Bevacizumab basic Characters
|Melt Point:||61 — 71°C|
|Storage Temp:||2 — 8°C|
Bevacizumab (216974-75-3) usage in steroids cycle
Bevacizumab (CAS 216974-75-3), also called Avastin and Mvasi.
Bevacizumab comes as a solution to administer slowly into a vein. Bevacizumab isadministered by a doctor or nurse in a medical office, infusion center, or hospital. Bevacizumab is usually given once every 2 or 3 weeks.
It should take 90 minutes for you to receive your first dose of bevacizumab. A doctor or nurse will watch you closely to see how your body reacts to Bevacizumab (216974-75-3) . Ifyou do not have any serious problems when you receive your first dose of bevacizumab, it will usually take 30 to 60 minutes for you to receive each of your remaining doses of the medication.
Bevacizumab injection may cause serious reactions during infusion of the medication. If you experience any of the following symptoms, tell your doctor immediately: difficulty breathing or shortness of breath, chills, shaking, sweating, headaches, chestpain, dizziness, feeling faint, flushing, itching, rash, or hives. Your doctor may need to slow down your infusion, or delay or stop your treatment if you experience these or other side effects.
Warning on Bevacizumab (216974-75-3)
Bevacizumab may disrupt normal menstrual cycles and impair fertility by several effects. Some parameters do not recover completely, or recover very slowly followingdiscontinuation of the drug.
Monoclonal antibodies are a relatively new type of “targeted” cancer therapy. Antibodies are part of the immune system. Normally, the body creates antibodies in response to an antigen (such as a protein in a germ) entering the body. The antibodies attach to the antigen in order to mark it for destruction by the body’s immune system. In the laboratory, scientists analyze specific antigens on the surface of cancer cells (target) to determine a protein to match the antigen. Then, using animaland human proteins, scientists work to create a special antibody that will attach to the target antigen. Antibodies will attach to matching antigens like a key fits a lock. This technology allows treatment to target specific cells, causing less toxicity tohealthy cells. Monoclonal antibody therapy can be done only for cancers in whichantigens (and the respective antibodies) have been identified.
Bevacizumab (216974-75-3) works by interfering with the process of angiogenesis by targeting and inhibiting human vascular endothelial growth factor (VEGF). VEGF is a cytokine (a small protein released by cells that have specific effects on the behavior of cells)which when it interacts with its receptors in the cell leads to new blood vessel formation or angiogenesis.
How to buy Bevacizumab from AASraw
1.To contact us by our email inquiry system,or online skypecustomer service representative(CSR).
2.To provide us your inquired quantity and address.
3.Our CSR will provide you the quotation, payment term, tracking number, delivery ways and estimated arrival date(ETA).
4.Payment done and the goods will be sent out in 12 hours(For order within 10kg).
5.Goods received and give comments.
PRECAUTION AND DISCLAIMER:
This Material is Sold For Research Use Only. Terms of Sale Apply. Not for Human Consumption, nor Medical, Veterinary, or Household Uses.